Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Gemcitabine Alone in Advanced Pancreatic Cancer

• 資料種別: 記事
• タイトル: Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Gemcitabine Alone in Advanced Pancreatic Cancer
• 著者標目: Volker Heinemann; Detlef Quietzsch; Frank Gieseler; Michael Gonnermann; Herbert Schönekäs; Andreas Rost; Horst Neuhaus; Caroline Haag; Michael Clemens; Bernard Heinrich; Ursula Vehling-Kaiser; Martin Fuchs; Doris Fleckenstein; Wolfgang Gesierich; Dirk Uthgenannt; Hermann Einsele; Axel Holstege; Axel Hinke; Andreas Schalhorn; Ralf Wilkowski
• 出版年月日等: 2006-08-20
• 出版年（W3CDTF）: 2006-08-20
• タイトル（掲載誌）: Journal of Clinical Oncology
• 巻号年月日等（掲載誌）: 24 24
• 掲載巻: 24
• 掲載号: 24
• 掲載ページ: 3946-3952
• 掲載年月日（W3CDTF）: 2006-08-20
• ISSN（掲載誌）: 0732183X; http://id.crossref.org/issn/0732183X
• 出版事項（掲載誌）: American Society of Clinical Oncology (ASCO)
• 対象利用者: 一般
• DOI: 10.1200/jco.2005.05.1490
• 作成日（W3CDTF）: 2006-08-18
• 関連情報（URI）: https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.05.1490
• 参照: Prognostic nomogram for nonresectable pancreatic cancer treated with gemcitabine-based chemotherapy; https://cir.nii.ac.jp/crid/1360002216786294912; Phase I/II clinical trial using HLA-A24-restricted peptide vaccine derived from KIF20A for patients with advanced pancreatic cancer; https://cir.nii.ac.jp/crid/1360004236790317824; Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study; https://cir.nii.ac.jp/crid/1360565168981121280; Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer; https://cir.nii.ac.jp/crid/1360567182331325696; Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations; https://cir.nii.ac.jp/crid/1360567186772868224; Randomized phase <scp>II</scp>/<scp>III</scp> clinical trial of elpamotide for patients with advanced pancreatic cancer: <scp>PEGASUS</scp>‐<scp>PC</scp> Study; https://cir.nii.ac.jp/crid/1360848660418381440; A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer; https://cir.nii.ac.jp/crid/1360848661749633024; Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site; https://cir.nii.ac.jp/crid/1360848661804316160; Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study); https://cir.nii.ac.jp/crid/1360853567392825600; 抗がん剤により膵癌細胞に誘導されるEMT促進因子の同定と機能解析; https://cir.nii.ac.jp/crid/1390001204640043904; Cancer of Unknown Primary Site in which Tumor Marker-Oriented Chemotherapy was Effective and Pancreatic Cancer was Finally Confirmed at Autopsy; https://cir.nii.ac.jp/crid/1390001204872076288; 領域加温によるハイパーサーミアを併用した全身化学療法; https://cir.nii.ac.jp/crid/1390282679329273728; 膵癌術後化学療法の進歩と展望; https://cir.nii.ac.jp/crid/1390282679615082496; 化学療法による急速な腫瘍壊死により十二指腸穿通をきたした膵頭部癌の一例; https://cir.nii.ac.jp/crid/1390282679615673088; 臨床開発中のＤＤＳ製剤 シスプラチン内包ミセルＮＣ‐６００４のイギリスでの臨床第Ｉ相試験を行って; https://cir.nii.ac.jp/crid/1390282679617746816; Efficacy and Safety of Gemcitabine Monotherapy for Patients with Advanced Biliary Tract Cancer; https://cir.nii.ac.jp/crid/1390282680073243136; 温熱化学療法が有効であった癌悪液質を伴った末期膵癌の一例; https://cir.nii.ac.jp/crid/1390282680263366144; Gemcitabine＋<i>nab</i>-Paclitaxel併用療法後に切除可能となった局所進行切除不能膵癌の1例; https://cir.nii.ac.jp/crid/1390282763046684544
• 連携機関・データベース: 国立情報学研究所 : CiNii Research; https://cir.nii.ac.jp/
• 提供元機関・データベース: Crossref; https://www.crossref.org; CiNii Articles
• NII論文ID: 30022792362

• 要約等: <jats:sec><jats:title>Purpose</jats:title><jats:p> To compare the effectiveness and tolerability of gemcitabine plus cisplatin with single-agent gemci...